[It's getting easier for terminally ill people to end their own lives.](https://www.marketwatch.com/story/its-getting-easier-for-terminally-ill-people-to-end-their-own-lives-what-to-know-as-laws-change-4fa04c54?mod=mw_rss_topstories) Most analysts buried this as a regulatory footnote. I see a structural threat to pharma's highest-margin franchise — end-of-life care, where pricing power is theoretically infinite because alternatives are "worse than death." That logic just evaporated.

Research these companies